Carl Domino’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Carl Domino’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-13,000	Closed	-$192K	–	126
2017 Q1	$192K	Sell	13,000 -2,000	-13%	-$32.4K	0.21%	106
2016 Q4	$243K	Hold	15,000	–	–	0.26%	88
2016 Q3	$267K	Hold	15,000	–	–	0.25%	96
2016 Q2	$247K	Buy	15,000 +4,000	+36%	+$64.7K	0.23%	98
2016 Q1	$182K	Hold	11,000	–	–	0.17%	120
2015 Q4	$238K	Buy	+11,000	New	+$214K	0.19%	107

Other funds holding HZNP

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Carl Domino's HZNP Position: Q2 2017 in Review

Carl Domino sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2017, closing a stake of 13,000 shares — an estimated $192K sold.

Carl Domino first reported a position in HZNP in Q4 2015 and held it in 6 quarters. The position peaked at $267K in Q3 2016. 190 funds tracked by Wall St. Rank hold HZNP as of Q2 2017.

Carl Domino reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2017 after selling out during the quarter.
Carl Domino sold 13,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2017, an estimated $192K.
Carl Domino first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 6 quarters.
Carl Domino's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $267K in Q3 2016.
190 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2017.

Based on Carl Domino's 13F filing for Q2 2017, filed 24 Jul 2017.